A Drug-Free ADHD Treatment for Kids Gets a Brain-Scan Network Behind It
The Globe and Mail
Firefly Neuroscience and NeuroSigma have partnered to integrate NeuroSigma's Monarch eTNS® System, a non-drug ADHD treatment, with Firefly's Evoke™ platform, which uses brain-scan data to provide objective insights into brain function. Monarch, cleared by the FDA for pediatric ADHD, delivers mild nerve stimulation during sleep and is now being introduced to Firefly's network of clinicians. The collaboration aims to offer more treatment options and objective evaluation tools for ADHD management.
All articles from 27 September 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.